Abstract:Adhesion of cancer cell to endothelial cells and the subsequent trans-endothelial migration are key steps in hematogenous metastasis. However, the molecular mechanisms of cancer cell/endothelial cell interaction under hemodynamic shear flow and how shear flow-induced cancer cell mechanotransduction are yet to be fully defined. In this study, we identified that the integrins of both platelet glycoprotein IIb/IIIa (GP IIb/IIIa) and αvβ3 were crucial for hematogenous metastasis of human breast carcinoma MDA-MB-231 cells. The cell migration and invasion were studied by using Millicell cell culture insert system. The numbers of invaded MDA-MB-231 cells significantly increased by thrombin-activated platelets and reduced by eptifibatide, a platelet inhibitor. Meanwhile, RGDWE peptides, a specific inhibitor of αvβ3 integrin, also inhibited MDA-MB-231 cell invasion. We further used a parallel-plate flow chamber to investigate MDA-MB-231 cell adhesion under flow conditions. Alike in static condition, the adhesion capability of MDA-MB-231 cells to endothelial monolayer was also significantly affected by GP IIb/IIIa and αvβ3 integrins. The expression of matrix metalloproteinase-2 (MMP-2), MMP-9 and αvβ3 integrin in MDA-MB-231 cells were up-regulated after low shear stress exposure (1.84 dynes/cm(2), 2 h). Moreover, we also demonstrated that low shear stress induced a sustained activation of p85 (a regulatory subunit of PI3K) and Akt. Pre-treating MDA-MB-231 cells with the specific PI3K inhibitor of LY294002 abolished the shear stress induced-Akt activation, and the expression of MMP-2, MMP-9, vascular endothelial growth factor (VEGF) and αvβ3 integrin were also down-regulated. Immunofluorescence assay showed that low shear stress also induced αvβ3 integrin clustering and nuclear factor-κB (NF-κB) activation. Interestingly, shear stress-induced activation of Akt and NF-κB was attenuated by LM609, a specific antibody of αvβ3 integrin. It suggests that αvβ3 integrin might be as a mechanosensor to trigger both PI3K/Akt and NF-κB signaling pathways. Taken together, these results establish that GP IIb/IIIa and αvβ3 integrins are essential mediators, and provide insight into how shear stress-induced αvβ3 integrin activation and the downstream pathways for contribution to MDA-MB-231 cell adhesion, migration and invasion.

Role of Beta3 Integrin in Pathological Angiogenesis

Integrin signaling is critical for pathological angiogenesis.

The Angiogenic Response is Dictated by Β3 Integrin on Bone Marrow–derived Cells

Integrin Affinity Modulation in Angiogenesis.

Thymosin beta4 induces angiogenesis through Notch signaling in endothelial cells

Integrin αvβ3-targeted cancer therapy

Integrin Alpha(v)beta(3)-Targeted Cancer Therapy.

Elucidation of the Roles of Tumor Integrin β1 in the Extravasation Stage of the Metastasis Cascade

The roles of integrin β4 in vascular endothelial cells.

The Effects of αvβ3 Integrin Blockage in Breast Tumor and Endothelial Cells under Hypoxia In Vitro

Research Progress on the Relationship Between Integrin and Angiogenesis

Differential roles of amino acid sequences of integrin β3 cytoplasmic tail in αvβ3-mediated cell behaviors

ANGPTL3 Stimulates Endothelial Cell Adhesion and Migration Via Integrin Αvβ3 and Induces Blood Vessel Formation in Vivo

Integrin αvβ3 mediates K1735 murine melanoma cell motility in vivo and in vitro

The Role of Adhesion Molecules, Alpha V Beta 3, Alpha V Beta 5 and Their Ligands in the Tumor Cell and Endothelial Cell Adhesion

Integrin signaling in cancer: bidirectional mechanisms and therapeutic opportunities

The Role of αvβ3 Integrin in Cancer Therapy Resistance

The Challenges and Opportunities of Αvβ3-Based Therapeutics in Cancer: from Bench to Clinical Trials

Angiogenesis in breast cancer: the role of transforming growth factor beta and CD105

Roles for GP IIb/IIIa and Αvβ3 Integrins in MDA-MB-231 Cell Invasion and Shear Flow-Induced Cancer Cell Mechanotransduction

Roles of Integrin Αvβ3 in Interleukin-8-mediated Metastasis and Angiogenesis of Estrogen Receptor Negative Breast Cancer Cells